Interleukin-6 Blockade as Rescue Therapy in Autoimmune Encephalitis - PMC
The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. Preview improvements coming to the PMC website in October 2024. Learn More or Try it out now. Brain Autoimmunity Group, Institute for Neuroscience and Muscle Research, the Children’s Hospital at Westmead, University of Sydney, Sydney, Australia Autoimmune encephalitis (AE) is an expanding group of inflammatory brain conditions defined by the presence of autoantibodies against cell-surface proteins such as neuronal receptors or synaptic proteins [1]. AE is important to suspect and diagnose, as early immune therapy appears to improve outcomes [2]. Wi
editorial Neurotherapeutics . 2016 Aug 16;13(4):821–823. doi: 10.1007/s13311-016-0471-1 Interleukin-6 Blockade as Rescue Therapy in Autoimmune Encephalitis Russell C Dale Russell C Dale 1 Brain Autoimmunity Group, Institute for Neuroscience and Muscle Research, the Children’s Hospital at Westmead, University of Sydney, Sydney, Australia Find articles by Russell C Dale 1, ✉ Author information Article notes Copyright and License information 1 Brain Autoimmunity Group, Institute for Neuroscience and Muscle Research, the Children’s Hospital at Westmead, University of Sydney, Sydney, Australia ✉ Co
saved by
related reading
- Immune Regulation | People | Osaka University Immunology Frontier Research Centerifrec.osaka-u.ac.jp
- Population pharmacokinetics of palivizumab, a humanized anti-respiratory syncytial virus monoclonal antibody, in adults and children - PubMedpubmed.ncbi.nlm.nih.gov
- A body–brain circuit that regulates body inflammatory responsesnature.com
- Sensitivity and specificity of phrenic nerve electrophysiology to predict mechanical ventilation in the Guillain-Barré syndrome - PubMedpubmed.ncbi.nlm.nih.gov
- From inflammation to sickness and depression: when the immune system subjugates the brainnature.com
- Frontiers | Inflammation: Bridging Age, Menopause and APOEε4 Genotype to Alzheimer’s Diseasefrontiersin.org
- Treatment of HIV-associated primary CNS lymphoma with antiretroviral therapy, rituximab, and high-dose methotrexatencbi.nlm.nih.gov
- Frontiers | Effect of inactivated COVID-19 vaccines on seizure frequency in patients with epilepsy: A multicenter, prospective studyfrontiersin.org
- Biomarkers for Alzheimer’s Disease in the Current State: A Narrative Review - PMCncbi.nlm.nih.gov
- Posterior reversible encephalopathy syndrome(PRES) - PMCncbi.nlm.nih.gov
- Association of anti-NXP2 antibody with clinical characteristics and outcomes in adult dermatomyositis: results from clinical applications based on a myositis-specific antibody - PubMedpubmed.ncbi.nlm.nih.gov
- Neural signal data collection and analysis of Percept™ PC BrainSense recordings for thalamic stimulation in epilepsy - PMCncbi.nlm.nih.gov